Nevertheless, it is conceivable that in the TME, TAMs can be exposed to human sPLA2s produced by tumor cells, stromal cells or other tumor-infiltrating immune cells such as mast cells [12,13,92]. This evidence concerns the gene PLA2G2D and neoplasm.